AUPH logo

Aurinia Pharmaceuticals (AUPH) Free cash flow

annual FCF:

$44.11M+$78.29M(+229.05%)
December 31, 2024

Summary

  • As of today (May 24, 2025), AUPH annual free cash flow is $44.11 million, with the most recent change of +$78.29 million (+229.05%) on December 31, 2024.
  • During the last 3 years, AUPH annual FCF has risen by +$203.30 million (+127.71%).
  • AUPH annual FCF is now at all-time high.

Performance

AUPH Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

quarterly FCF:

$1.28M-$28.77M(-95.73%)
March 31, 2025

Summary

  • As of today (May 24, 2025), AUPH quarterly free cash flow is $1.28 million, with the most recent change of -$28.77 million (-95.73%) on March 31, 2025.
  • Over the past year, AUPH quarterly FCF has increased by +$19.89 million (+106.89%).
  • AUPH quarterly FCF is now -95.73% below its all-time high of $30.06 million, reached on December 31, 2024.

Performance

AUPH quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

TTM FCF:

$64.00M+$19.89M(+45.10%)
March 31, 2025

Summary

  • As of today (May 24, 2025), AUPH TTM free cash flow is $64.00 million, with the most recent change of +$19.89 million (+45.10%) on March 31, 2025.
  • Over the past year, AUPH TTM FCF has increased by +$84.61 million (+410.53%).
  • AUPH TTM FCF is now at all-time high.

Performance

AUPH TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

AUPH Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+229.1%+106.9%+410.5%
3 y3 years+127.7%+102.7%+142.3%
5 y5 years+169.3%+105.6%+187.3%

AUPH Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+127.7%-95.7%+102.7%at high+142.3%
5 y5-yearat high+127.7%-95.7%+102.3%at high+140.2%
alltimeall timeat high+127.7%-95.7%+102.3%at high+140.2%

AUPH Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.28M(-95.7%)
$64.00M(+45.1%)
Dec 2024
$44.11M(-229.0%)
$30.06M(+77.9%)
$44.11M(+55.8%)
Sep 2024
-
$16.90M(+7.2%)
$28.30M(-1674.1%)
Jun 2024
-
$15.76M(-184.7%)
-$1.80M(-91.3%)
Mar 2024
-
-$18.61M(-230.6%)
-$20.61M(-39.7%)
Dec 2023
-$34.18M(-57.2%)
$14.25M(-208.0%)
-$34.18M(-10.3%)
Sep 2023
-
-$13.20M(+332.4%)
-$38.12M(-5.5%)
Jun 2023
-
-$3.05M(-90.5%)
-$40.32M(-38.1%)
Mar 2023
-
-$32.18M(-411.9%)
-$65.17M(-18.3%)
Dec 2022
-$79.82M(-49.9%)
$10.32M(-167.0%)
-$79.82M(-31.4%)
Sep 2022
-
-$15.40M(-44.8%)
-$116.36M(-17.7%)
Jun 2022
-
-$27.91M(-40.4%)
-$141.37M(-6.6%)
Mar 2022
-
-$46.83M(+78.6%)
-$151.30M(-5.0%)
Dec 2021
-$159.19M(+106.2%)
-$26.23M(-35.1%)
-$159.19M(+20.6%)
Sep 2021
-
-$40.41M(+6.8%)
-$131.95M(+6.2%)
Jun 2021
-
-$37.84M(-30.9%)
-$124.23M(+13.9%)
Mar 2021
-
-$54.72M(-5459.6%)
-$109.10M(+41.3%)
Dec 2020
-$77.20M(+21.2%)
$1.02M(-103.1%)
-$77.20M(-25.5%)
Sep 2020
-
-$32.70M(+44.0%)
-$103.66M(+25.2%)
Jun 2020
-
-$22.71M(-0.5%)
-$82.77M(+12.9%)
Mar 2020
-
-$22.82M(-10.3%)
-$73.34M(+15.2%)
Dec 2019
-$63.69M(+23.2%)
-$25.44M(+115.5%)
-$63.69M(+22.7%)
Sep 2019
-
-$11.80M(-11.1%)
-$51.88M(+0.9%)
Jun 2019
-
-$13.28M(+0.8%)
-$51.41M(+1.9%)
Mar 2019
-
-$13.17M(-3.4%)
-$50.45M(-2.4%)
Dec 2018
-$51.69M(+25.5%)
-$13.64M(+20.4%)
-$51.69M(+10.0%)
Sep 2018
-
-$11.33M(-8.1%)
-$46.99M(+6.3%)
Jun 2018
-
-$12.32M(-14.5%)
-$44.19M(-3.7%)
Mar 2018
-
-$14.40M(+61.1%)
-$45.88M(+11.4%)
Dec 2017
-$41.19M(+119.8%)
-$8.94M(+4.9%)
-$41.19M(+12.8%)
Sep 2017
-
-$8.53M(-39.2%)
-$36.53M(+13.5%)
Jun 2017
-
-$14.01M(+44.2%)
-$32.20M(+38.6%)
Mar 2017
-
-$9.72M(+127.2%)
-$23.24M(+24.0%)
Dec 2016
-$18.74M(+5.2%)
-$4.28M(+2.0%)
-$18.74M(-2.9%)
Sep 2016
-
-$4.19M(-17.0%)
-$19.30M(-5.1%)
Jun 2016
-
-$5.05M(-3.3%)
-$20.33M(+7.0%)
Mar 2016
-
-$5.22M(+7.9%)
-$19.00M(+6.7%)
Dec 2015
-$17.82M(+4.8%)
-$4.84M(-7.4%)
-$17.82M(+9.0%)
Sep 2015
-
-$5.23M(+40.5%)
-$16.35M(+7.8%)
Jun 2015
-
-$3.72M(-7.8%)
-$15.16M(-3.3%)
Mar 2015
-
-$4.03M(+19.7%)
-$15.68M(-7.8%)
Dec 2014
-$17.00M(+259.5%)
-$3.37M(-16.7%)
-$17.00M(+4.9%)
Sep 2014
-
-$4.04M(-4.4%)
-$16.20M(+18.5%)
Jun 2014
-
-$4.23M(-21.0%)
-$13.68M(+38.5%)
Mar 2014
-
-$5.36M(+108.2%)
-$9.88M(+108.9%)
Dec 2013
-$4.73M(-28.2%)
-$2.57M(+69.1%)
-$4.73M(+60.6%)
Sep 2013
-
-$1.52M(+255.4%)
-$2.94M(+9.9%)
Jun 2013
-
-$428.00K(+106.8%)
-$2.68M(-46.1%)
Mar 2013
-
-$207.00K(-73.8%)
-$4.97M(-24.5%)
Dec 2012
-$6.59M(+162.8%)
-$788.70K(-37.2%)
-$6.59M(-7.6%)
Sep 2012
-
-$1.25M(-53.9%)
-$7.12M(+1.4%)
Jun 2012
-
-$2.72M(+49.6%)
-$7.03M(+20.6%)
Mar 2012
-
-$1.82M(+37.2%)
-$5.83M(+132.5%)
DateAnnualQuarterlyTTM
Dec 2011
-$2.51M(-46.3%)
-$1.33M(+14.4%)
-$2.51M(+27.8%)
Sep 2011
-
-$1.16M(-23.7%)
-$1.96M(-17.7%)
Jun 2011
-
-$1.52M(-201.3%)
-$2.38M(+35.7%)
Mar 2011
-
$1.50M(-292.2%)
-$1.76M(-62.4%)
Dec 2010
-$4.67M(-56.3%)
-$780.90K(-50.6%)
-$4.67M(-14.3%)
Sep 2010
-
-$1.58M(+76.7%)
-$5.45M(-0.9%)
Jun 2010
-
-$894.60K(-36.6%)
-$5.49M(-38.0%)
Mar 2010
-
-$1.41M(-9.5%)
-$8.86M(-17.1%)
Dec 2009
-$10.69M(-39.7%)
-$1.56M(-4.3%)
-$10.69M(+0.5%)
Sep 2009
-
-$1.63M(-61.7%)
-$10.63M(-3.3%)
Jun 2009
-
-$4.26M(+31.3%)
-$11.00M(+0.3%)
Mar 2009
-
-$3.24M(+115.4%)
-$10.97M(-38.1%)
Dec 2008
-$17.73M(-39.6%)
-$1.51M(-24.5%)
-$17.73M(-22.0%)
Sep 2008
-
-$1.99M(-52.8%)
-$22.73M(-25.2%)
Jun 2008
-
-$4.23M(-57.7%)
-$30.37M(-8.2%)
Mar 2008
-
-$10.00M(+53.7%)
-$33.08M(+12.8%)
Dec 2007
-$29.33M(+31.8%)
-$6.51M(-32.5%)
-$29.33M(+2.9%)
Sep 2007
-
-$9.64M(+38.9%)
-$28.49M(+18.9%)
Jun 2007
-
-$6.94M(+11.1%)
-$23.97M(+10.1%)
Mar 2007
-
-$6.24M(+10.2%)
-$21.78M(-2.1%)
Dec 2006
-$22.25M(+1.3%)
-$5.67M(+10.7%)
-$22.25M(+0.3%)
Sep 2006
-
-$5.12M(+7.8%)
-$22.18M(+7.6%)
Jun 2006
-
-$4.75M(-29.3%)
-$20.61M(-5.5%)
Mar 2006
-
-$6.72M(+20.0%)
-$21.80M(-0.7%)
Dec 2005
-$21.96M(+4.5%)
-$5.60M(+58.0%)
-$21.96M(-7.4%)
Sep 2005
-
-$3.54M(-40.4%)
-$23.72M(-9.4%)
Jun 2005
-
-$5.94M(-13.6%)
-$26.20M(+5.7%)
Mar 2005
-
-$6.88M(-6.6%)
-$24.79M(+17.9%)
Dec 2004
-$21.02M(+184.3%)
-$7.36M(+22.4%)
-$21.02M(+40.7%)
Sep 2004
-
-$6.02M(+32.5%)
-$14.94M(-7.2%)
Jun 2004
-
-$4.54M(+46.3%)
-$16.10M(+149.1%)
Mar 2004
-
-$3.10M(+143.4%)
-$6.46M(-12.6%)
Dec 2003
-$7.39M(+38.1%)
-$1.28M(-82.2%)
-$7.39M(-31.7%)
Sep 2003
-
-$7.18M(-240.9%)
-$10.82M(+1257.9%)
Jun 2003
-
$5.09M(-226.2%)
-$796.80K(-86.1%)
Mar 2003
-
-$4.04M(-14.1%)
-$5.74M(+7.3%)
Dec 2002
-$5.35M(-33.3%)
-$4.70M(-265.1%)
-$5.35M(+720.9%)
Sep 2002
-
$2.85M(+1833.9%)
-$652.10K(-80.8%)
Jun 2002
-
$147.20K(-104.0%)
-$3.40M(-46.4%)
Mar 2002
-
-$3.65M(-3622.7%)
-$6.34M(-20.1%)
Dec 2001
-$8.02M(+25.9%)
-
-
Aug 2001
-
$103.50K(-103.7%)
-$7.93M(-16.4%)
May 2001
-
-$2.79M(-4.5%)
-$9.48M(+16.8%)
Feb 2001
-
-$2.92M(+26.4%)
-$8.12M(+27.5%)
Nov 2000
-$6.37M(+368.9%)
-$2.31M(+59.3%)
-$6.37M(+38.1%)
Aug 2000
-
-$1.45M(+1.5%)
-$4.61M(+40.4%)
May 2000
-
-$1.43M(+22.2%)
-$3.28M(+26.5%)
Feb 2000
-
-$1.17M(+111.0%)
-$2.60M(+91.1%)
Nov 1999
-$1.36M(-28.1%)
-$555.30K(+345.3%)
-$1.36M(+69.2%)
Aug 1999
-
-$124.70K(-83.3%)
-$802.90K(+18.4%)
May 1999
-
-$744.50K(-1222.9%)
-$678.20K(-1122.9%)
Feb 1999
-
$66.30K
$66.30K
Nov 1998
-$1.89M
-
-

FAQ

  • What is Aurinia Pharmaceuticals annual free cash flow?
  • What is the all time high annual FCF for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals annual FCF year-on-year change?
  • What is Aurinia Pharmaceuticals quarterly free cash flow?
  • What is the all time high quarterly FCF for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals quarterly FCF year-on-year change?
  • What is Aurinia Pharmaceuticals TTM free cash flow?
  • What is the all time high TTM FCF for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals TTM FCF year-on-year change?

What is Aurinia Pharmaceuticals annual free cash flow?

The current annual FCF of AUPH is $44.11M

What is the all time high annual FCF for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high annual free cash flow is $44.11M

What is Aurinia Pharmaceuticals annual FCF year-on-year change?

Over the past year, AUPH annual free cash flow has changed by +$78.29M (+229.05%)

What is Aurinia Pharmaceuticals quarterly free cash flow?

The current quarterly FCF of AUPH is $1.28M

What is the all time high quarterly FCF for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high quarterly free cash flow is $30.06M

What is Aurinia Pharmaceuticals quarterly FCF year-on-year change?

Over the past year, AUPH quarterly free cash flow has changed by +$19.89M (+106.89%)

What is Aurinia Pharmaceuticals TTM free cash flow?

The current TTM FCF of AUPH is $64.00M

What is the all time high TTM FCF for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high TTM free cash flow is $64.00M

What is Aurinia Pharmaceuticals TTM FCF year-on-year change?

Over the past year, AUPH TTM free cash flow has changed by +$84.61M (+410.53%)
On this page